Study Shows Promise for Expensive Cholesterol Drugs, but They Are Still Hard to Obtain

A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.
By GINA KOLATA from NYT Health http://ift.tt/2gcPQO0
via IFTTT
Cholesterol, Health Insurance and Managed Care, Drugs (Pharmaceuticals)
Source The New York Times
Làm đẹp Blog 247